CAR T-cell Infusion Following Checkpoint Inhibition Can Induce Remission in Chemorefractory Post-transplant Lymphoproliferative Disorder of the CNS

• Wiebke Rösler,
• Andrea Bink,
• Marina Bissig,
• Lukas Imbach,
• Ewerton Marques Maggio,
• Markus G. Manz,
• Thomas Müller,
• Patrick Roth,
• Elisabeth Rushing,
• Corinne Widmer,
• Thorsten Zenz,
• Seraina von Moos,
• Antonia M. S. Müller

Affiliations

Wiebke Rösler

1 Department of Medical Oncology and Hematology, University Hospital Zurich, Switzerland

Andrea Bink

2 Department of Neuroradiology, University Hospital Zurich, Switzerland

Marina Bissig

1 Department of Medical Oncology and Hematology, University Hospital Zurich, Switzerland

Lukas Imbach

3 Department of Neurology, University Hospital Zurich, Switzerland

Ewerton Marques Maggio

4 Institute of Pathology and Molecular Pathology, University Hospital Zurich, Switzerland

Markus G. Manz

1 Department of Medical Oncology and Hematology, University Hospital Zurich, Switzerland

Thomas Müller

5 Department of Nephrology, University Hospital Zurich, Switzerland

Patrick Roth

3 Department of Neurology, University Hospital Zurich, Switzerland

Elisabeth Rushing

6 Institute of Neuropathology, University Hospital Zurich, Switzerland

Corinne Widmer

1 Department of Medical Oncology and Hematology, University Hospital Zurich, Switzerland

Thorsten Zenz

1 Department of Medical Oncology and Hematology, University Hospital Zurich, Switzerland

Seraina von Moos

5 Department of Nephrology, University Hospital Zurich, Switzerland

Antonia M. S. Müller

1 Department of Medical Oncology and Hematology, University Hospital Zurich, Switzerland